{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:18:52Z","timestamp":1787728732659,"version":"build-2784847793"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006507","name":"Deshpande Center for Technological Innovation at MIT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Focal epilepsy is a difficult disease to treat as two-thirds of patients will not respond to oral anti-seizure medications (ASMs) or have severe off-target effects that lead to drug discontinuation. Current non-pharmaceutical treatment methods (resection or ablation) are underutilized due to the associated morbidities, invasive nature and inaccessibility of seizure foci. Less invasive non-ablative modalities may potentially offer an alternative. Targeting the seizure focus in this way may avoid unassociated critical brain structures to preserve function and alleviate seizure burden.<\/jats:p>\n               <jats:p>Here we report use of an implantable, miniaturized neural drug delivery system [microinvasive neural implant infusion platform (MINI)] to administer ASMs directly to the seizure focus in a mouse model of temporal lobe epilepsy. We examined the effect local delivery of phenobarbital and valproate had on focal seizures, as well as adverse effects, and compared this to systemic delivery.<\/jats:p>\n               <jats:p>We show that local delivery of phenobarbital and valproate using our chronic implants significantly reduced focal seizures at all doses given. Furthermore, we show that local delivery of these compounds resulted in no adverse effects to motor function, whereas systemic delivery resulted in significant motor impairment.<\/jats:p>\n               <jats:p>The results of this study demonstrate the potential of ASM micro dosing to the epileptic focus as a treatment option for people with drug resistant epilepsy. This technology could also be applied to a variety of disease states, enabling a deeper understanding of focal drug delivery in the treatment of neurological disorders.<\/jats:p>","DOI":"10.1093\/brain\/awae282","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:28:52Z","timestamp":1725582532000},"page":"4147-4156","source":"Crossref","is-referenced-by-count":6,"title":["Intracerebral delivery of antiseizure medications by microinvasive neural implants"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-6802","authenticated-orcid":false,"given":"Hannah D","family":"Jackson","sequence":"first","affiliation":[{"name":"Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology , Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J","family":"Cotler","sequence":"additional","affiliation":[{"name":"Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology , Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W","family":"Saunders","sequence":"additional","affiliation":[{"name":"Anticonvulsant Drug Development Program, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carena A","family":"Cornelssen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]},{"name":"Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"West","sequence":"additional","affiliation":[{"name":"Anticonvulsant Drug Development Program, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]},{"name":"Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron S","family":"Metcalf","sequence":"additional","affiliation":[{"name":"Anticonvulsant Drug Development Program, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]},{"name":"Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2660-8826","authenticated-orcid":false,"given":"Karen S","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Anticonvulsant Drug Development Program, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]},{"name":"Department of Biomedical Engineering, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]},{"name":"Department of Pharmacology and Toxicology, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Cima","sequence":"additional","affiliation":[{"name":"Department of Materials Science and Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology , Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"2024121304085134200_awae282-B1","doi-asserted-by":"crossref","first-page":"1273163","DOI":"10.3389\/fepid.2023.1273163","article-title":"Editorial: Epidemiology of epilepsy and seizures","volume":"3","author":"Chen","year":"2023","journal-title":"Front Epidemiol."},{"key":"2024121304085134200_awae282-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: An overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2024121304085134200_awae282-B3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"},{"key":"2024121304085134200_awae282-B4","doi-asserted-by":"crossref","first-page":"e2589","DOI":"10.1002\/brb3.2589","article-title":"The burden of epilepsy and unmet need in people with focal seizures","volume":"12","author":"Ioannou","year":"2022","journal-title":"Brain Behav"},{"key":"2024121304085134200_awae282-B5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: From bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"key":"2024121304085134200_awae282-B6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4314\/ahs.v23i2.84","article-title":"Multiple anti-seizure medications use and pattern of seizure control in children with epilepsy at neurology follow up clinic, Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia","volume":"23","author":"Endayen","year":"2023","journal-title":"Afr Health Sci"},{"key":"2024121304085134200_awae282-B7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: Improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St. Louis","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"2024121304085134200_awae282-B8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11064-017-2262-4","article-title":"Neurodevelopmental effects of antiepileptic drugs","volume":"42","author":"Kellogg","year":"2017","journal-title":"Neurochem Res"},{"key":"2024121304085134200_awae282-B9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav."},{"key":"2024121304085134200_awae282-B10","doi-asserted-by":"crossref","first-page":"674483","DOI":"10.3389\/fneur.2021.674483","article-title":"The pharmacoresistant epilepsy: An overview on existant and new emerging therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front Neurol"},{"key":"2024121304085134200_awae282-B11","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical management of drug resistant epilepsy: A review on current strategies","volume":"17","author":"Guery","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2024121304085134200_awae282-B12","doi-asserted-by":"crossref","first-page":"A765","DOI":"10.1016\/j.jval.2015.09.2510","article-title":"Humanistic and economic burden of focal drug-refractory epilepsy in Europe","volume":"18","author":"Vrouchou","year":"2015","journal-title":"Value Health."},{"key":"2024121304085134200_awae282-B13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2011.09.008","article-title":"Antiepileptic drug combinations--have newer agents altered clinical outcomes?","volume":"98","author":"Stephen","year":"2012","journal-title":"Epilepsy Res"},{"key":"2024121304085134200_awae282-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.0032","article-title":"Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy","volume":"77","author":"Alsfouk","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024121304085134200_awae282-B15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.9740\/mhc.2015.01.008","article-title":"Pharmacokinetic characteristics of antiepileptic drugs (AEDs)","volume":"6","author":"Marvanova","year":"2016","journal-title":"Ment Health Clin"},{"key":"2024121304085134200_awae282-B16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/npr2.12196","article-title":"Neuropharmacology of antiseizure drugs","volume":"41","author":"Hakami","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"2024121304085134200_awae282-B17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.121.000994","article-title":"Therapeutic basis of generic substitution of antiseizure medications","volume":"381","author":"Elmer","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"2024121304085134200_awae282-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-1824-2","article-title":"Potential problems and recommendations regarding substitution of generic antiepileptic drugs: A systematic review of literature","volume":"5","author":"Atif","year":"2016","journal-title":"Springerplus"},{"key":"2024121304085134200_awae282-B19","volume-title":"StatPearls","author":"Lewis","year":"2024"},{"key":"2024121304085134200_awae282-B20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABAA receptors","volume":"22","author":"Greenfield","year":"2013","journal-title":"Seizure"},{"issue":"Suppl.","key":"2024121304085134200_awae282-B21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yebeh.2005.01.008","article-title":"Pharmacological outcomes in newly diagnosed epilepsy","volume":"6","author":"Mohanraj","year":"2005","journal-title":"Epilepsy Behav."},{"key":"2024121304085134200_awae282-B23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1039\/C6LC01411A","article-title":"A three dimensional in vitro glial scar model to investigate the local strain effects from micromotion around neural implants","volume":"17","author":"Spencer","year":"2017","journal-title":"Lab Chip"},{"key":"2024121304085134200_awae282-B24","doi-asserted-by":"crossref","first-page":"e1901459","DOI":"10.1002\/smll.201901459","article-title":"Steerable microinvasive probes for localized drug delivery to deep tissue","volume":"15","author":"Cotler","year":"2019","journal-title":"Small"},{"key":"2024121304085134200_awae282-B25","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1073\/pnas.1804372115","article-title":"Focal, remote-controlled, chronic chemical modulation of brain microstructures","volume":"115","author":"Ramadi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121304085134200_awae282-B26","doi-asserted-by":"crossref","first-page":"eaan2742","DOI":"10.1126\/scitranslmed.aan2742","article-title":"Miniaturized neural system for chronic, local intracerebral drug delivery","volume":"10","author":"Dagdeviren","year":"2018","journal-title":"Sci Transl Med"},{"key":"2024121304085134200_awae282-B27","doi-asserted-by":"crossref","first-page":"107734","DOI":"10.1016\/j.celrep.2020.107734","article-title":"Computationally guided intracerebral drug delivery via chronically implanted microdevices ll computationally guided intracerebral drug delivery via chronically implanted microdevices","volume":"31","author":"Ramadi","year":"2020","journal-title":"Cell Rep."},{"key":"2024121304085134200_awae282-B28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/epi.16406","article-title":"A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies","volume":"61","author":"Welzel","year":"2020","journal-title":"Epilepsia"},{"issue":"10 Pt 2","key":"2024121304085134200_awae282-B29","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","article-title":"The kainic acid model of temporal lobe epilepsy","volume":"37","author":"L\u00e9vesque","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"2024121304085134200_awae282-B30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/epi4.2","article-title":"The effects of carbamazepine in the intrahippocampal kainate model of temporal lobe epilepsy depend on seizure definition and mouse strain","volume":"1","author":"Twele","year":"2016","journal-title":"Epilepsia Open"},{"key":"2024121304085134200_awae282-B31","first-page":"497","article-title":"Differential effects of antiepileptic drugs on focal seizures in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy","volume":"22","author":"Duveau","year":"2016","journal-title":"CNS"},{"key":"2024121304085134200_awae282-B32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2014.11.008","article-title":"Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice","volume":"90","author":"Klein","year":"2015","journal-title":"Neuropharmacology"},{"key":"2024121304085134200_awae282-B33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature"},{"key":"2024121304085134200_awae282-B34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneumeth.2014.09.019","article-title":"A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models","volume":"238","author":"Thomson","year":"2014","journal-title":"J Neurosci Methods"},{"key":"2024121304085134200_awae282-B35","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/epi.17402","article-title":"Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach","volume":"63","author":"Mensah","year":"2022","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1523\/ENEURO.0158-18.2018","article-title":"Targeting the mouse ventral hippocampus in the intrahippocampal kainic acid model of temporal lobe epilepsy","volume":"5","author":"Zeidler","year":"2018","journal-title":"eNeuro"},{"key":"2024121304085134200_awae282-B37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J Am Pharm Assoc Am Pharm Assoc (Baltim)"},{"key":"2024121304085134200_awae282-B38","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/epi.13476","article-title":"Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice","volume":"57","author":"Barker-Haliski","year":"2016","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0b013e318250d7ea","article-title":"Epilepsy surgery trends in the United States, 1990\u20132008","volume":"78","author":"Englot","year":"2012","journal-title":"Neurology"},{"key":"2024121304085134200_awae282-B40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/WCO.0000000000000528","article-title":"The current place of epilepsy surgery","volume":"31","author":"Engel","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"2024121304085134200_awae282-B41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1474-4422(16)30127-2","article-title":"Surgical treatment for epilepsy: The potential gap between evidence and practice","volume":"15","author":"Jett\u00e9","year":"2016","journal-title":"Lancet Neurol"},{"key":"2024121304085134200_awae282-B42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/epi.12161","article-title":"Complications of epilepsy surgery\u2014A systematic review of focal surgical resections and invasive EEG monitoring","volume":"54","author":"Hader","year":"2013","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000504856","article-title":"Clinically significant visual deficits after Laser interstitial thermal therapy for mesiotemporal epilepsy","volume":"97","author":"Jermakowicz","year":"2019","journal-title":"Stereotact Funct Neurosurg"},{"key":"2024121304085134200_awae282-B44","doi-asserted-by":"crossref","first-page":"107837","DOI":"10.1016\/j.yebeh.2021.107837","article-title":"Underutilization of epilepsy surgery: Part I: A scoping review of barriers HHS public access","volume":"117","author":"Samanta","year":"2021","journal-title":"Epilepsy Behav"},{"key":"2024121304085134200_awae282-B45","doi-asserted-by":"crossref","first-page":"100326","DOI":"10.1016\/j.eclinm.2020.100326","article-title":"Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man study","volume":"22","author":"Cook","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2024121304085134200_awae282-B46","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/epi.17625","article-title":"Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities","volume":"64","author":"Fahoum","year":"2023","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B47","doi-asserted-by":"crossref","first-page":"eaau1291","DOI":"10.1126\/sciadv.aau1291","article-title":"Electrophoretic drug delivery for seizure control","volume":"4","author":"Proctor","year":"2018","journal-title":"Sci Adv"},{"key":"2024121304085134200_awae282-B48","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/epi.16624","article-title":"Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred versus inbred mice","volume":"61","author":"Koneval","year":"2020","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2013.12.015","article-title":"Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler\u2019s virus model of temporal lobe epilepsy","volume":"64","author":"Umpierre","year":"2014","journal-title":"Neurobiol Dis"},{"key":"2024121304085134200_awae282-B50","doi-asserted-by":"crossref","first-page":"107811","DOI":"10.1016\/j.neuropharm.2019.107811","article-title":"The current approach of the epilepsy therapy screening program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy","volume":"166","author":"Wilcox","year":"2020","journal-title":"Neuropharmacology"},{"key":"2024121304085134200_awae282-B51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"2024121304085134200_awae282-B52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3181\/00379727-121-30878","article-title":"Circadian analysis of phenobarbital \u2014 Induced hyperkinesia in mice and hamsters","volume":"121","author":"Millichamp","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"key":"2024121304085134200_awae282-B53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/epi.13946","article-title":"Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy","volume":"59","author":"Guilfoyle","year":"2018","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B54","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1528-1157.2001.09701.x","article-title":"Secondarily generalized seizures in mesial temporal epilepsy: Clinical characteristics, lateralizing signs, and association with sleep\u2013wake cycle","volume":"42","author":"Jobst","year":"2001","journal-title":"Epilepsia"},{"key":"2024121304085134200_awae282-B55","doi-asserted-by":"crossref","first-page":"113954","DOI":"10.1016\/j.expneurol.2021.113954","article-title":"Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs","volume":"349","author":"West","year":"2022","journal-title":"Exp Neurol"},{"key":"2024121304085134200_awae282-B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: An emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J Clin Med"},{"key":"2024121304085134200_awae282-B57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainresbull.2019.05.024","article-title":"Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors","volume":"150","author":"Puhl","year":"2019","journal-title":"Brain Res Bull"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae282\/59759296\/awae282.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/12\/4147\/60939660\/awae282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/12\/4147\/60939660\/awae282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:09:54Z","timestamp":1734062994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/12\/4147\/7750480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,9,6]]},"published-print":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae282","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,9,6]]}}}